BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 25561510)

  • 21. Designing immunotoxins for cancer therapy.
    Pennell CA; Erickson HA
    Immunol Res; 2002; 25(2):177-91. PubMed ID: 11999171
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunotoxin therapy for cancer.
    Pai LH; Pastan I
    JAMA; 1993 Jan; 269(1):78-81. PubMed ID: 8416411
    [No Abstract]   [Full Text] [Related]  

  • 23. Immunotoxins in the treatment of hematologic malignancies.
    Kreitman RJ; Pastan I
    Curr Drug Targets; 2006 Oct; 7(10):1301-11. PubMed ID: 17073592
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recombinant immunotoxins for cancer therapy.
    Brinkmann U; Keppler-Hafkemeyer A; Hafkemeyer P
    Expert Opin Biol Ther; 2001 Jul; 1(4):693-702. PubMed ID: 11727505
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeted toxins in brain tumor therapy.
    Li YM; Hall WA
    Toxins (Basel); 2010 Nov; 2(11):2645-62. PubMed ID: 22069569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of relative binding affinity on efficacy in a panel of anti-CD3 scFv immunotoxins.
    Hexham JM; Dudas D; Hugo R; Thompson J; King V; Dowling C; Neville DM; Digan ME; Lake P
    Mol Immunol; 2001 Sep; 38(5):397-408. PubMed ID: 11684296
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunotoxins.
    Press OW
    Biotherapy; 1991; 3(1):65-76. PubMed ID: 2009215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunotoxin treatment of cancer.
    Pastan I; Hassan R; FitzGerald DJ; Kreitman RJ
    Annu Rev Med; 2007; 58():221-37. PubMed ID: 17059365
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patents on immunotoxins and chimeric toxins for the treatment of cancer.
    Bachran C; Sutherland M; Bachran D; Fuchs H
    Recent Pat Drug Deliv Formul; 2007; 1(2):105-15. PubMed ID: 19075878
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunotoxins in cancer therapy.
    Kreitman RJ
    Curr Opin Immunol; 1999 Oct; 11(5):570-8. PubMed ID: 10508704
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recombinant single-chain and disulfide-stabilized Fv-immunotoxins that cause complete regression of a human colon cancer xenograft in nude mice.
    Reiter Y; Wright AF; Tonge DW; Pastan I
    Int J Cancer; 1996 Jul; 67(1):113-23. PubMed ID: 8690511
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Critical Issues in the Development of Immunotoxins for Anticancer Therapy.
    Kim JS; Jun SY; Kim YS
    J Pharm Sci; 2020 Jan; 109(1):104-115. PubMed ID: 31669121
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunotoxins and recombinant toxins in the treatment of solid carcinomas.
    Theuer CP; Pastan I
    Am J Surg; 1993 Sep; 166(3):284-8. PubMed ID: 8368439
    [TBL] [Abstract][Full Text] [Related]  

  • 34. First immunotoxin therapy for many common solid tumors enters phase I clinical trial.
    Skolnick AA
    JAMA; 1993 Nov; 270(19):2280. PubMed ID: 8230582
    [No Abstract]   [Full Text] [Related]  

  • 35. Immunotoxin targeting EpCAM effectively inhibits peritoneal tumor growth in experimental models of mucinous peritoneal surface malignancies.
    Flatmark K; Guldvik IJ; Svensson H; Fleten KG; Flørenes VA; Reed W; Giercksky KE; Fodstad Ø; Andersson Y
    Int J Cancer; 2013 Sep; 133(6):1497-506. PubMed ID: 23494569
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of solid tumors with immunotoxins.
    Messmer D; Kipps TJ
    Breast Cancer Res; 2005; 7(5):184-6. PubMed ID: 16168135
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunotoxins: a clinical review of their use in the treatment of malignancies.
    Hertler AA; Frankel AE
    J Clin Oncol; 1989 Dec; 7(12):1932-42. PubMed ID: 2685183
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeted anticancer immunotoxins and cytotoxic agents with direct killing moieties.
    Kawakami K; Nakajima O; Morishita R; Nagai R
    ScientificWorldJournal; 2006 Jul; 6():781-90. PubMed ID: 16830050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunotoxins in the treatment of refractory hairy cell leukemia.
    Kreitman RJ; Pastan I
    Hematol Oncol Clin North Am; 2006 Oct; 20(5):1137-51, viii. PubMed ID: 16990113
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting Receptors on Cancer Cells with Protein Toxins.
    Antignani A; Ho ECH; Bilotta MT; Qiu R; Sarnvosky R; FitzGerald DJ
    Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32957689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.